European Committee for Treatment and Research in MS (ECTRIMS) 31st Congress – Barcelona, Spain, October 7-10, 2015 – The Late Breaking session at ECTRIMS 2015 was especially interesting this year as new data were presented on several novel MS treatments. Read More
Latest News
Quality of life in schizophrenia: the QUALIFY trial
October 14, 2015QUALIFY study
Commentary from Dr. Ofer Agid
Considerable advances have been made in recent decades in the management of schizophrenia. A majority of first-episode patients achieve remission of psychotic symptoms within the first year of treatment (Lieberman et al. Arch Gen Psychiatry 1993;50:369-376), and early recurrence rates are low (Zipursky et al. Schizophr Res 2014;152:408-414). Read More
Long-term outcomes of HSCT in MS
October 10, 2015REPORT FROM ECTRIMS – BARCELONA, SPAIN – OCTOBER 7-10, 2015 – The MS-AHSCT Long-Term Outcomes Study Group has compiled data for MS patients undergoing autologous hematopoietic stem cell transplantation (HSCT) during the period 1995-2006 to determine long-term outcomes (Muraro et al. ECTRIMS 2015; abstract 1671). A total of 281 patients from 25 centres were evaluable. The median duration of follow-up was 6.6 years (range 0.2-16 years). Read More
Need for early, effective treatment: MSBase investigators
October 10, 2015REPORT FROM ECTRIMS – BARCELONA, SPAIN – OCTOBER 7-10, 2015 – There is a need for early intervention with more effective therapies to slow disability progression, according to a series of analyses by the MSBase investigators. Read More